Substance Use Disorder Assessment (Formerly Substance Abuse Assessment)
- Changes in Mood
- Poor Hygiene
- Odd Sleep Patterns
- Frequent Injuries
- Relationship or Job Difficulty
- Poor Performance
- Anorexia OR Weight Loss
- Social Isolation
- Financial Problems
Alcohol Use Disorder Assessment (Formerly Alcohol Abuse Assessment)
- CNS Depression
- Wernicke-Korsakoff Syndrome
- GI Distress
- Cardiomyopathy
- Pancreatitis
- Cirrhosis
- Immunosuppression
- Sexual Dysfunction
- Screening (Assessments)
Alcohol Use Disorder Interventions (Formerly Alcohol Abuse Interventions)
- Reduce Environmental Stimuli
- Antianxiety Medications
- Vitamin Supplements
- Seizure Precautions
- Suicide Precautions
- Fever
- Identify Support Systems
- Group Therapy
- Disulfiram
- Naltrexone
Opioid Use Disorder and Withdrawal Assessment (Formerly Opioid Abuse and Withdrawal Assessment)
- Euphoria
- Miosis
- CNS Depression
- Yawning
- Gooseflesh
- Sweating
- Rhinorrhea
- Kicking Movements
- Naloxone
Amphetamines Intoxication Assessment
- Euphoria
- Insomnia
- Mydriasis
- Diaphoresis
- Hypertension
- Tachycardia
- Paranoia
- Anxiety
- Anorexia
- Seizures
Marijuana Intoxication Assessment
- Euphoria
- Slowed Reaction Time
- Conjunctival Injection
- Increased Appetite
- Anxiety
- Social Withdrawal
- Paranoid Delusions
Benzodiazepine Intoxication Assessment
- Drowsiness
- Confusion
- Respiratory Depression
- Hypotension
- Coma
- Flumazenil (Romazicon)
Cocaine Intoxication Assessment
- Euphoria
- Delusions
- Mydriasis
- Hallucinations
- Agitation
- Hypertension
- Arrhythmias
- Hyperthermia
- Seizures
- Nasal Septum Perforation
LSD Intoxication Assessment
- Psychosis
- Perceptual Distortion
- Visual Hallucinations
- Paranoia
- Depersonalization
- Anxiety
- Tachycardia
- Flashbacks
Phencyclidine (PCP) Intoxication Assessment
- Violent Behavior
- Motor Issues
- Nystagmus
- Increased Pain Tolerance
- Tachycardia
- Delirium
- Seizures
- Psychosis
Delirium
- Rapid Onset
- Reversible
- Hallucinations
- Decline in Cognition
- Short Attention Span
- Rapid Speech
- Change in Activity Level
- Mood Swings
MDMA (Ecstasy) Toxicity: Management
- Airway Management
- Management of Hypertension
- Benzodiazapines
- Nitroprusside
- Activated Charcoal if Within One Hour of Ingestion
- Ice Bath if Hyperthermic
- Cyproheptadine if Serotonin Syndrome
- Fluid Restriction for Hyponatremia
- Hypertonic Saline if Hyponatremia + Altered Mental Status
MDMA (Ecstasy) Toxicity: Mechanism and Clinical Findings
- Sympathomimetic
- Increases Release and Blocks Reuptake of Catecholamines
- Euphoria
- Increased Alertness
- Extreme Hyponatremia Leading to Altered Mental Status
- Acute Liver Injury
- Serotonin Syndrome
- Rhabdomyolysis
- Hypertensive Urgency/Emergency
- Arrhythmia
Substance Use Disorder
- 2 or More Symptoms For 1 year
- Tolerance
- Withdrawal Symptoms
- Cravings
- Using More Than Intended
- Inability to Cut Down
- Time-Consuming Substance Acquisition
- Impaired Functioning at Work
- Reduced Recreational Activities
- Dangerous Activities
- Continued Use
Delirium Tremens
- 2-4 Days After Last Drink
- Alcohol Withdrawal
- Altered Mental Status (Change In LOC)
- Anxiety
- Hallucinations
- Autonomic Instability
- Seizures
- Insomnia
- Nausea/Vomiting
- Benzodiazepines
- Supportive Care
Antidepressant Discontinuation Syndrome
- FINISH Mnemonic
- Flu-Like Symptoms
- Insomnia
- Nausea
- Imbalance
- Sensory Disturbances
- Hyperarousal
- Restart and Taper
Buprenorphine-Naloxone (Suboxone)
- Combination Drug
- Partial Opioid Receptor Agonist (Buprenorphine)
- Opioid Receptor Antagonist (Naloxone)
- Opioid Use Disorder
- CNS Depression
- Diaphoresis
- Hypotension
- Low Abuse Potential